German, American Team Confirms CYP2D6 Influence on Tamoxifen Response

Using a retrospective study involving more than 1,300 women with breast cancer, a group of researchers from Germany and the US found that individuals carrying poorer metabolizing versions of the CYP2D6 enzyme had increased rates of cancer recurrence.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.